<DOC>
	<DOCNO>NCT00019786</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Giving drug different way may kill tumor cell . PURPOSE : This phase II trial study well isolate hepatic perfusion melphalan work treat patient primary unresectable liver cancer liver metastasis .</brief_summary>
	<brief_title>Isolated Hepatic Perfusion With Melphalan Treating Patients With Primary Unresectable Liver Cancer Liver Metastases</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate , duration response , pattern recurrence patient primary metastatic , unresectable cancer liver treatment isolate hepatic perfusion melphalan . - Determine disease-free overall survival patient treat regimen . OUTLINE : Patients otherwise eligible undergo exploratory laparotomy peritoneal cavity . Patients peritoneal seeding , unresectable extrahepatic metastasis , unresectable pathologically-involved lymph node outside area portahepatis receive treatment . Remaining patient receive isolated hepatic perfusion melphalan . Liver perfusion proceeds 1 hour . Patients follow 6 week , every 3 month 2 year , every 4 month disease progression . PROJECTED ACCRUAL : A maximum 67 patient accrue study .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Carcinoma , Neuroendocrine</mesh_term>
	<mesh_term>Adenoma , Islet Cell</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically proven liver cancer meet 1 follow criterion : Primary unresectable hepatocellular cholangiocellular carcinoma Metastatic cancer liver originate one following : Intraocular melanoma ( close accrual 10/17/03 ) Islet cell carcinoma Adenocarcinoma colon rectum limit parenchyma liver No evidence unresectable extrahepatic colorectal metastasis Other neuroendocrine tumor , carcinoid tumor Measurable disease PATIENT CHARACTERISTICS : Age : Any age Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Platelet count great 100,000/mm^3 Hematocrit great 27.0 % WBC least 2,500/mm^3 Hepatic : Bilirubin le 2.0 mg/dL ( 3.0 mg/dL patient Gilbert 's syndrome ) PT great 2 second upper limit normal Elevated SGOT SGPT allow due hepatitis No biopsyproven cirrhosis evidence significant portal hypertension No prior concurrent venoocclusive disease Patients positive hepatitis B C surface antigen serology chronic active hepatitis eligible provide evidence cirrhosis Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance great 60 mL/min Cardiovascular : Congestive heart failure allow LVEF â‰¥ 40 % Pulmonary : No chronic obstructive pulmonary disease chronic pulmonary disease pulmonary function test less 50 % predict age Other : Weight great 30 kg Not pregnant nursing Negative pregnancy test No active infection PRIOR CONCURRENT THERAPY : Biologic therapy : At least 1 month since prior anticancer biologic therapy recover Chemotherapy : At least 1 month since prior anticancer chemotherapy recover Endocrine therapy : Not specify Radiotherapy : At least 1 month since prior anticancer radiotherapy recover Surgery : Not specify Other : Prior intrahepatic arterial infusion therapy allow No chronic use anticoagulants No concurrent immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>localize unresectable adult primary liver cancer</keyword>
	<keyword>recurrent adult primary liver cancer</keyword>
	<keyword>recurrent islet cell carcinoma</keyword>
	<keyword>adult primary hepatocellular carcinoma</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>liver metastasis</keyword>
	<keyword>adult primary cholangiocellular carcinoma</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>recurrent childhood liver cancer</keyword>
	<keyword>childhood hepatocellular carcinoma</keyword>
	<keyword>stage III childhood liver cancer</keyword>
	<keyword>stage IV childhood liver cancer</keyword>
	<keyword>neuroendocrine carcinoma</keyword>
</DOC>